Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Trading and Strategy Update

28 Nov 2022 07:00

RNS Number : 7020H
Barkby Group PLC
28 November 2022
 

28 November 2022

Barkby Group PLC

("Barkby", the "Group" or the "Company")

Trading and Strategy Update

 

Barkby Group PLC (AIM:BARK), the diversified business group, is pleased to provide the following update on trading and an update on the Group's future strategy.

 

Trading Update

 

Barkby Real Estate

 

· The focus of the Group remains on building and scaling a high-quality, substantial portfolio of modern, ESG compliant Roadside real estate investments.

· Since July construction has progressed well at our commercial schemes at Wellingborough and Maldon.

· Wellingborough is scheduled to complete construction next month and it is our intention to hold the development on our balance sheet as an investment as we grow a high-quality commercial property portfolio.

The total contracted rent is £234,000 per annum with contracted tenants being Greggs Plc, Formula One Autocentres Ltd, City Plumbing Supplies Holdings Ltd and C. Brewers & Sons Ltd. The WAULT is 12.9 years and all leases are RPI or CPI linked.

· Maldon is scheduled to complete construction by April 2023, we will also hold this development on our balance sheet.

The total expected rent is £268,000 per annum with contracted tenants being Costa Coffee Ltd, Formula One Autocentres Ltd, Toolstation Ltd with the remaining unit under offer. The WAULT is 12.1 years and all leases are RPI or CPI linked.

· A revised planning application has been submitted for a 27,000 sq.ft. scheme at Swindon, we expect decision in Q1 2023. The scheme will be anchored by a national Drive Thru operator with a trade and industrial occupiers taking the remainder of the site.

· Given downward valuation pressure in the commercial property market over the last 6 months we are seeing high quality assets, at attractive valuations, becoming available with a lot less competition to acquire. 

· We are seeing a significant opportunity to scale our pipeline, and are in negotiations on a number of new Roadside developments and investments. We are targeting increasing our ongoing pipeline to £200m.

 

Barkby Pub Co

 

· Revenue 3% down year on year compared with Q1 2021, broadly in line with the overall sector as household spending decreases.

· Christmas bookings look strong and we remain optimistic for a strong festive trading period.

· Addition of the Eliot Arms pub at South Cerney to take the pub estate to nine units and 75 bedrooms.

· Majority of our energy contracts were fixed in December 2020 until December 2023, so the business is well protected from the wider energy cost pressures facing the industry.

· Inflationary pressures on labour, food and drink margins are in line with the wider hospitality sector.

· Whilst we continue to grow the pub portfolio the Board continues to review future strategy of the PubCo.

 

 

 

 

Barkby Investments

 

· As previously announced, we completed the sale of the Verso Biosense stake for £2.6m in August 2022.

· Following our announcement to sell our non-core businesses in July 2022, we provide the following update:

 

Workshop Coffee - a sales process was launched in September 2022. This has coincided with a strong recovery in the business as it returns to pre-pandemic levels. The sales process is progressing, with discussions ongoing with a number of interested parties under NDA.

Centurian Automotive - the business will be transferred out the Group on the 1 January 2023, with the existing management team acquiring the ongoing business for nil overall consideration.

Cambridge Sleep Sciences - over the summer CSS has developed several significant licensing opportunities with global technology companies for the IP behind SleepHub. The previously launched sales process has been paused whilst these opportunities progress. The Board believes that completion of these licensing opportunities will have a material impact on the potential valuation of the CSS business.

 

Future Strategy

 

In our July 2022 update the Board announced it had determined to focus on roadside property development and investment and to dispose of all the Group's other businesses and investments. As we move towards implementing this strategic change, we expect that all non-core businesses, including Barkby Pub Co. Ltd will not form part of the Group moving forward.

 

In recent months, we have met a number of prospective institutional investors and have received positive feedback around scaling our Roadside property investment and development business and continue to explore doing so.  The Group continues to look at several routes to maximise the opportunity this pureplay real estate strategy presents and is considering funding options, including both equity and debt to take advantage of the pipeline of opportunities highlighted above. We are also reviewing the most tax efficient way of holding a high-quality, substantial portfolio of modern, ESG compliant Roadside real estate investments, including becoming a REIT. We are also looking to further strengthen the Board as we make this pursue our focused roadside strategy. 

 

Debt Re-financing

 

As we look to expand our real estate business and hold existing developments, we have in principle agreed a re-financing of the existing Tarncourt facility from £5m to £10m with expiry being extended from 30th June 2023 to 30th June 2024. A separate announcement will be made once all the terms have agreed, and the documentation has been finalised. The re-financing will go to strengthen the Group's balance sheet and working capital.

 

Results

 

We expect to release our full year results in December 2022.

 

Commenting, Charles Dickson, Executive Chairman, said: 

 

"FollowFollowing on from our July announcement we have made good progress in streamlining the Group. We have completed the sale of our stake in Verso Biosense and made further progress exiting the remaining non-core businesses.

 

We remain focussed on scaling the real estate business, with a particular focus on high quality modern sustainable roadside developments in the form of drive-thru's, trade counter, last mile logistics, convenience food, EV charging hubs and light industrial commercial buildings. Our view is that this strategy, once scaled, has the ability to deliver double digit annualised total accounting returns."

 

Enquiries:

 

Barkby Group PLC

Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer

finnCap Ltd (Nomad and Broker)

+44 (0) 20 7220 0500

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 

Camarco (Financial PR)

+44 (0) 20 3757 4994

Jennifer Renwick/Phoebe Pugh

 

 

 

Notes to editors

Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include; Barkby Real Estate, Barkby Pub Co. and Barkby Investments (Comprising of Workshop Coffee, Centurian Automotive and Cambridge Sleep Sciences).

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (596/2014/EU) as it forms part of UK domestic law by virtue of the European Union (withdrawal) act 2018 ("MAR").

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFEIEEWEESEIF
12
Date   Source Headline
30th Jan 20246:03 pmRNSChange of Name to Roadside Real Estate plc
2nd Jan 20247:00 amRNSResult of General Meeting
19th Dec 202311:15 amRNSUpdate on debt refinancing and CSS
15th Dec 20237:00 amRNSFirst joint venture acquisition
13th Dec 20235:39 pmRNSPosting of Circular and Notice of General Meeting
4th Dec 20237:00 amRNSIntention to refinance debt facilities
7th Nov 20237:00 amRNSPractical completion of second Roadside asset
31st Oct 20237:00 amRNSFormation of Roadside Real Estate Joint Venture
29th Sep 20237:00 amRNSTrading update
19th Sep 20237:00 amRNSCSS Announces Licensing Deal with Mammoth
11th Sep 20237:00 amRNSResponse to media speculation re CSS
1st Aug 20237:00 amRNSDisposal of Workshop Coffee
14th Jun 20237:42 amRNSCSS announces new licensing agreement
9th Jun 20237:00 amRNSPub portfolio update
6th Jun 20237:00 amRNSMajor licensing deal for Cambridge Sleep Sciences
31st May 20237:00 amRNSPractical completion of first Roadside asset
15th May 20237:00 amRNSBoard Update, Equity Issue & Total Voting Rights
31st Mar 20237:00 amRNSInterim results
22nd Feb 20235:26 pmRNSResult of AGM
16th Jan 20237:00 amRNSNotice of AGM & Debt Facility Drawing
30th Dec 20227:01 amRNSFinal results for the year ended 2 July 2022
30th Dec 20227:00 amRNSRevised debt facility
28th Nov 20227:00 amRNSTrading and Strategy Update
25th Nov 20227:00 amRNSAcquisition of the Eliot Arms
7th Sep 20225:48 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSTrading and Strategy Update
21st Jun 20223:19 pmRNSDirector/PDMR Shareholding
11th May 20225:21 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSExchange of Contracts at Saffron Walden, Essex
1st Apr 20227:00 amRNSAcquisition of The Coach and Horses
30th Mar 20227:20 amRNSInterim Results
4th Mar 20226:09 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSAppointment of Group Property Director
2nd Mar 20227:00 amRNSVerso Biosense completes clinical study
1st Mar 20227:00 amRNSBoard Update
8th Feb 20225:35 pmRNSResult of AGM
3rd Feb 20223:33 pmRNSIssue of Equity and Total Voting Rights
25th Jan 20227:00 amRNSCambridge Sleep Sciences Announces New Partners
18th Jan 20227:00 amRNSVerso Biosense study nears completion
13th Jan 20227:00 amRNSPosting of Annual Report & Notice of AGM
24th Dec 20217:00 amRNSFinal Results for the Year Ended 1 July 2021
20th Dec 20212:06 pmRNSSecond Price Monitoring Extn
20th Dec 20212:00 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSExchange of Contracts in Swindon, Wiltshire
27th Oct 20214:41 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20212:05 pmRNSSecond Price Monitoring Extn
27th Oct 20212:00 pmRNSPrice Monitoring Extension
27th Oct 202111:05 amRNSSecond Price Monitoring Extn
27th Oct 202111:00 amRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.